Literature DB >> 5556189

Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.

W M Kirby, J B De Maine, W S Serrill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5556189

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  26 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Effect of diuretics on urinary excretion of cephalothin in humans.

Authors:  A D Tice; M Barza; M G Bergeron; J L Brusch; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

4.  Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.

Authors:  P F Sonneville; R R Kartodirdjo; H Skeggs; A E Till; C M Martin
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

5.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 7.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

8.  Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.

Authors:  M F Rein; F B Westervelt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

9.  The pharmacokinetics of cefuroxime after intravenous injection.

Authors:  P E Gower; C H Dash
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

10.  Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.

Authors:  P F Sonneville; K S Albert; H Skeggs; H Gentner; K C Kwan; C M Martin
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.